Timber Pharmaceuticals, Inc.
Timber Pharmaceuticals, Inc. (TMBR) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
tmbr · pe ratio · data through Dec 31, 2022
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Timber Pharmaceuticals, Inc. (TMBR) measures how much investors pay for each dollar of the company's trailing earnings. TMBR's current PE ratio of N/A is calculated by dividing its stock price of $0.34 by its TTM earnings per share of -$9.19.
Source: FMP · /ratios-ttm · /analyst-estimates · 2022-12-31
PE Ratio History
2011 – 2022 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Timber Pharmaceuticals, Inc.You TMBR | $1M | N/A | — | -$9.19 |
 Bellicum Pharmaceuticals, Inc. BLCM | $1M | N/A | — | -$0.81 |
 CohBar, Inc. CWBR | $1M | N/A | — | -$4.13 |
 Altamira Therapeutics Ltd. CYTO | $1M | N/A | — | $0.00 |
 HTG Molecular Diagnostics, Inc. HTGMQ | $0M | N/A | — | -$24.28 |
 Impel Pharmaceuticals Inc. IMPL | $1M | N/A | — | -$5.52 |
 NeuBase Therapeutics, Inc. NBSE | $1M | N/A | — | -$21.08 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2022-12-31Latest FY2022 | — | $-9.19 | — | |
2021-12-31 FY2021 | — | $-13.15 | — | |
2020-12-31 FY2020 | — | $-48.15 | — | |
2020-01-31 FY2020 | — | $-29.31 | — | |
2019-01-31 FY2019 | — | $-1340.11 | — | |
2018-01-31 FY2018 | — | $-1567.94 | — | |
2017-01-31 FY2017 | — | $-7710.93 | — | |
2016-01-31 FY2016 | — | $-13030.91 | — | |
2014-12-31 FY2014 | — | $0.00 | — | |
2013-09-30 FY2013 | — | $-0.01 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Timber Pharmaceuticals, Inc. (TMBR) measures how much investors pay for each dollar of the company's trailing earnings. TMBR's current PE ratio of N/A is calculated by dividing its stock price of $0.34 by its TTM earnings per share of -$9.19.
Frequently asked questions
TMBR pe ratio · 6 questionsTMBR's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.34 and TTM EPS of -$9.19. Data sourced from Financial Modeling Prep via TMBR's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Timber Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09